103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
HB2472

 

Introduced 2/15/2023, by Rep. Bob Morgan

 

SYNOPSIS AS INTRODUCED:
 
See Index

    Amends the Managed Care Reform and Patient Rights Act. Provides that if a health care plan uses an automated process to make an initial adverse determination or relies on a utilization review organization's automated process for an initial adverse determination, the health care plan shall ensure that any appeal is processed as required by the provisions, including the restriction that only a clinical peer may review an appeal. Provides that an automated process of a health care plan or registered utilization review program may make an initial adverse determination for services not included under specified provisions. Provides that utilization review programs that use automated processes to render an adverse determination shall base all adverse determinations on objective, evidence-based criteria that have been accredited by the American Accreditation Healthcare Commission or by the National Committee for Quality Assurance and shall provide proof of such accreditation to the Department of Insurance with any required registration. Provides that the utilization review program shall include with its registration materials attachments that contain specified policies and procedures. Amends the Health Carrier External Review Act. Changes the definition of "adverse determination". Amends the Prior Authorization Reform Act. Provides that if a health insurance issuer imposes a penalty for the failure to obtain any form of prior authorization for any health care service, the penalty may not exceed the lesser of the actual cost of the health care service or $1,000 per occurrence in addition to the plan cost-sharing provisions. Provides that a health insurance issuer may not require both the enrollee and the health care professional or health care provider to obtain any form of prior authorization for the same instance of a health care service, nor otherwise require more than one prior authorization for the same instance of a health care service. Makes conforming changes in the Illinois Insurance Code and the Network Adequacy and Transparency Act. Effective January 1, 2024.


LRB103 28761 BMS 55144 b

 

 

A BILL FOR

 

HB2472LRB103 28761 BMS 55144 b

1    AN ACT concerning regulation.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Insurance Code is amended by
5changing Sections 155.36 and 370s as follows:
 
6    (215 ILCS 5/155.36)
7    Sec. 155.36. Managed Care Reform and Patient Rights Act.
8Insurance companies that transact the kinds of insurance
9authorized under Class 1(b) or Class 2(a) of Section 4 of this
10Code shall comply with Sections 45, 45.1, 45.2, 65, 70, and 85,
11subsection (d) of Section 30, and the definition of the term
12"emergency medical condition" in Section 10 of the Managed
13Care Reform and Patient Rights Act. Except as provided by
14Section 85 of the Managed Care Reform and Patient Rights Act,
15no law or rule shall be construed to exempt any utilization
16review program from the requirements of Section 85 with
17respect to any insurance described in this Section.
18(Source: P.A. 101-608, eff. 1-1-20; 102-409, eff. 1-1-22.)
 
19    (215 ILCS 5/370s)
20    Sec. 370s. Managed Care Reform and Patient Rights Act. All
21administrators shall comply with Sections 55 and 85 of the
22Managed Care Reform and Patient Rights Act. Except as provided

 

 

HB2472- 2 -LRB103 28761 BMS 55144 b

1by Section 85 of the Managed Care Reform and Patient Rights
2Act, no law or rule shall be construed to exempt any
3utilization review program from the requirements of Section 85
4with respect to any insured or beneficiary described in this
5Article.
6(Source: P.A. 91-617, eff. 1-1-00.)
 
7    Section 10. The Network Adequacy and Transparency Act is
8amended by changing Section 10 as follows:
 
9    (215 ILCS 124/10)
10    Sec. 10. Network adequacy.
11    (a) An insurer providing a network plan shall file a
12description of all of the following with the Director:
13        (1) The written policies and procedures for adding
14    providers to meet patient needs based on increases in the
15    number of beneficiaries, changes in the
16    patient-to-provider ratio, changes in medical and health
17    care capabilities, and increased demand for services.
18        (2) The written policies and procedures for making
19    referrals within and outside the network.
20        (3) The written policies and procedures on how the
21    network plan will provide 24-hour, 7-day per week access
22    to network-affiliated primary care, emergency services,
23    and women's principal health care providers.
24    An insurer shall not prohibit a preferred provider from

 

 

HB2472- 3 -LRB103 28761 BMS 55144 b

1discussing any specific or all treatment options with
2beneficiaries irrespective of the insurer's position on those
3treatment options or from advocating on behalf of
4beneficiaries within the utilization review, grievance, or
5appeals processes established by the insurer in accordance
6with any rights or remedies available under applicable State
7or federal law.
8    (b) Insurers must file for review a description of the
9services to be offered through a network plan. The description
10shall include all of the following:
11        (1) A geographic map of the area proposed to be served
12    by the plan by county service area and zip code, including
13    marked locations for preferred providers.
14        (2) As deemed necessary by the Department, the names,
15    addresses, phone numbers, and specialties of the providers
16    who have entered into preferred provider agreements under
17    the network plan.
18        (3) The number of beneficiaries anticipated to be
19    covered by the network plan.
20        (4) An Internet website and toll-free telephone number
21    for beneficiaries and prospective beneficiaries to access
22    current and accurate lists of preferred providers,
23    additional information about the plan, as well as any
24    other information required by Department rule.
25        (5) A description of how health care services to be
26    rendered under the network plan are reasonably accessible

 

 

HB2472- 4 -LRB103 28761 BMS 55144 b

1    and available to beneficiaries. The description shall
2    address all of the following:
3            (A) the type of health care services to be
4        provided by the network plan;
5            (B) the ratio of physicians and other providers to
6        beneficiaries, by specialty and including primary care
7        physicians and facility-based physicians when
8        applicable under the contract, necessary to meet the
9        health care needs and service demands of the currently
10        enrolled population;
11            (C) the travel and distance standards for plan
12        beneficiaries in county service areas; and
13            (D) a description of how the use of telemedicine,
14        telehealth, or mobile care services may be used to
15        partially meet the network adequacy standards, if
16        applicable.
17        (6) A provision ensuring that whenever a beneficiary
18    has made a good faith effort, as evidenced by accessing
19    the provider directory, calling the network plan, and
20    calling the provider, to utilize preferred providers for a
21    covered service and it is determined the insurer does not
22    have the appropriate preferred providers due to
23    insufficient number, type, unreasonable travel distance or
24    delay, or preferred providers refusing to provide a
25    covered service because it is contrary to the conscience
26    of the preferred providers, as protected by the Health

 

 

HB2472- 5 -LRB103 28761 BMS 55144 b

1    Care Right of Conscience Act, the insurer shall ensure,
2    directly or indirectly, by terms contained in the payer
3    contract, that the beneficiary will be provided the
4    covered service at no greater cost to the beneficiary than
5    if the service had been provided by a preferred provider.
6    This paragraph (6) does not apply to: (A) a beneficiary
7    who willfully chooses to access a non-preferred provider
8    for health care services available through the panel of
9    preferred providers, or (B) a beneficiary enrolled in a
10    health maintenance organization. In these circumstances,
11    the contractual requirements for non-preferred provider
12    reimbursements shall apply unless Section 356z.3a of the
13    Illinois Insurance Code requires otherwise. In no event
14    shall a beneficiary who receives care at a participating
15    health care facility be required to search for
16    participating providers under the circumstances described
17    in subsection (b) or (b-5) of Section 356z.3a of the
18    Illinois Insurance Code except under the circumstances
19    described in paragraph (2) of subsection (b-5).
20        (7) A provision that the beneficiary shall receive
21    emergency care coverage such that payment for this
22    coverage is not dependent upon whether the emergency
23    services are performed by a preferred or non-preferred
24    provider and the coverage shall be at the same benefit
25    level as if the service or treatment had been rendered by a
26    preferred provider. For purposes of this paragraph (7),

 

 

HB2472- 6 -LRB103 28761 BMS 55144 b

1    "the same benefit level" means that the beneficiary is
2    provided the covered service at no greater cost to the
3    beneficiary than if the service had been provided by a
4    preferred provider. This provision shall be consistent
5    with Section 356z.3a of the Illinois Insurance Code.
6        (8) A limitation that complies with subsections (d)
7    and (e) of Section 55 of the Prior Authorization Reform
8    Act , if the plan provides that the beneficiary will incur
9    a penalty for failing to pre-certify inpatient hospital
10    treatment, the penalty may not exceed $1,000 per
11    occurrence in addition to the plan cost sharing
12    provisions.
13    (c) The network plan shall demonstrate to the Director a
14minimum ratio of providers to plan beneficiaries as required
15by the Department.
16        (1) The ratio of physicians or other providers to plan
17    beneficiaries shall be established annually by the
18    Department in consultation with the Department of Public
19    Health based upon the guidance from the federal Centers
20    for Medicare and Medicaid Services. The Department shall
21    not establish ratios for vision or dental providers who
22    provide services under dental-specific or vision-specific
23    benefits. The Department shall consider establishing
24    ratios for the following physicians or other providers:
25            (A) Primary Care;
26            (B) Pediatrics;

 

 

HB2472- 7 -LRB103 28761 BMS 55144 b

1            (C) Cardiology;
2            (D) Gastroenterology;
3            (E) General Surgery;
4            (F) Neurology;
5            (G) OB/GYN;
6            (H) Oncology/Radiation;
7            (I) Ophthalmology;
8            (J) Urology;
9            (K) Behavioral Health;
10            (L) Allergy/Immunology;
11            (M) Chiropractic;
12            (N) Dermatology;
13            (O) Endocrinology;
14            (P) Ears, Nose, and Throat (ENT)/Otolaryngology;
15            (Q) Infectious Disease;
16            (R) Nephrology;
17            (S) Neurosurgery;
18            (T) Orthopedic Surgery;
19            (U) Physiatry/Rehabilitative;
20            (V) Plastic Surgery;
21            (W) Pulmonary;
22            (X) Rheumatology;
23            (Y) Anesthesiology;
24            (Z) Pain Medicine;
25            (AA) Pediatric Specialty Services;
26            (BB) Outpatient Dialysis; and

 

 

HB2472- 8 -LRB103 28761 BMS 55144 b

1            (CC) HIV.
2        (2) The Director shall establish a process for the
3    review of the adequacy of these standards, along with an
4    assessment of additional specialties to be included in the
5    list under this subsection (c).
6    (d) The network plan shall demonstrate to the Director
7maximum travel and distance standards for plan beneficiaries,
8which shall be established annually by the Department in
9consultation with the Department of Public Health based upon
10the guidance from the federal Centers for Medicare and
11Medicaid Services. These standards shall consist of the
12maximum minutes or miles to be traveled by a plan beneficiary
13for each county type, such as large counties, metro counties,
14or rural counties as defined by Department rule.
15    The maximum travel time and distance standards must
16include standards for each physician and other provider
17category listed for which ratios have been established.
18    The Director shall establish a process for the review of
19the adequacy of these standards along with an assessment of
20additional specialties to be included in the list under this
21subsection (d).
22    (d-5)(1) Every insurer shall ensure that beneficiaries
23have timely and proximate access to treatment for mental,
24emotional, nervous, or substance use disorders or conditions
25in accordance with the provisions of paragraph (4) of
26subsection (a) of Section 370c of the Illinois Insurance Code.

 

 

HB2472- 9 -LRB103 28761 BMS 55144 b

1Insurers shall use a comparable process, strategy, evidentiary
2standard, and other factors in the development and application
3of the network adequacy standards for timely and proximate
4access to treatment for mental, emotional, nervous, or
5substance use disorders or conditions and those for the access
6to treatment for medical and surgical conditions. As such, the
7network adequacy standards for timely and proximate access
8shall equally be applied to treatment facilities and providers
9for mental, emotional, nervous, or substance use disorders or
10conditions and specialists providing medical or surgical
11benefits pursuant to the parity requirements of Section 370c.1
12of the Illinois Insurance Code and the federal Paul Wellstone
13and Pete Domenici Mental Health Parity and Addiction Equity
14Act of 2008. Notwithstanding the foregoing, the network
15adequacy standards for timely and proximate access to
16treatment for mental, emotional, nervous, or substance use
17disorders or conditions shall, at a minimum, satisfy the
18following requirements:
19        (A) For beneficiaries residing in the metropolitan
20    counties of Cook, DuPage, Kane, Lake, McHenry, and Will,
21    network adequacy standards for timely and proximate access
22    to treatment for mental, emotional, nervous, or substance
23    use disorders or conditions means a beneficiary shall not
24    have to travel longer than 30 minutes or 30 miles from the
25    beneficiary's residence to receive outpatient treatment
26    for mental, emotional, nervous, or substance use disorders

 

 

HB2472- 10 -LRB103 28761 BMS 55144 b

1    or conditions. Beneficiaries shall not be required to wait
2    longer than 10 business days between requesting an initial
3    appointment and being seen by the facility or provider of
4    mental, emotional, nervous, or substance use disorders or
5    conditions for outpatient treatment or to wait longer than
6    20 business days between requesting a repeat or follow-up
7    appointment and being seen by the facility or provider of
8    mental, emotional, nervous, or substance use disorders or
9    conditions for outpatient treatment; however, subject to
10    the protections of paragraph (3) of this subsection, a
11    network plan shall not be held responsible if the
12    beneficiary or provider voluntarily chooses to schedule an
13    appointment outside of these required time frames.
14        (B) For beneficiaries residing in Illinois counties
15    other than those counties listed in subparagraph (A) of
16    this paragraph, network adequacy standards for timely and
17    proximate access to treatment for mental, emotional,
18    nervous, or substance use disorders or conditions means a
19    beneficiary shall not have to travel longer than 60
20    minutes or 60 miles from the beneficiary's residence to
21    receive outpatient treatment for mental, emotional,
22    nervous, or substance use disorders or conditions.
23    Beneficiaries shall not be required to wait longer than 10
24    business days between requesting an initial appointment
25    and being seen by the facility or provider of mental,
26    emotional, nervous, or substance use disorders or

 

 

HB2472- 11 -LRB103 28761 BMS 55144 b

1    conditions for outpatient treatment or to wait longer than
2    20 business days between requesting a repeat or follow-up
3    appointment and being seen by the facility or provider of
4    mental, emotional, nervous, or substance use disorders or
5    conditions for outpatient treatment; however, subject to
6    the protections of paragraph (3) of this subsection, a
7    network plan shall not be held responsible if the
8    beneficiary or provider voluntarily chooses to schedule an
9    appointment outside of these required time frames.
10    (2) For beneficiaries residing in all Illinois counties,
11network adequacy standards for timely and proximate access to
12treatment for mental, emotional, nervous, or substance use
13disorders or conditions means a beneficiary shall not have to
14travel longer than 60 minutes or 60 miles from the
15beneficiary's residence to receive inpatient or residential
16treatment for mental, emotional, nervous, or substance use
17disorders or conditions.
18    (3) If there is no in-network facility or provider
19available for a beneficiary to receive timely and proximate
20access to treatment for mental, emotional, nervous, or
21substance use disorders or conditions in accordance with the
22network adequacy standards outlined in this subsection, the
23insurer shall provide necessary exceptions to its network to
24ensure admission and treatment with a provider or at a
25treatment facility in accordance with the network adequacy
26standards in this subsection.

 

 

HB2472- 12 -LRB103 28761 BMS 55144 b

1    (e) Except for network plans solely offered as a group
2health plan, these ratio and time and distance standards apply
3to the lowest cost-sharing tier of any tiered network.
4    (f) The network plan may consider use of other health care
5service delivery options, such as telemedicine or telehealth,
6mobile clinics, and centers of excellence, or other ways of
7delivering care to partially meet the requirements set under
8this Section.
9    (g) Except for the requirements set forth in subsection
10(d-5), insurers who are not able to comply with the provider
11ratios and time and distance standards established by the
12Department may request an exception to these requirements from
13the Department. The Department may grant an exception in the
14following circumstances:
15        (1) if no providers or facilities meet the specific
16    time and distance standard in a specific service area and
17    the insurer (i) discloses information on the distance and
18    travel time points that beneficiaries would have to travel
19    beyond the required criterion to reach the next closest
20    contracted provider outside of the service area and (ii)
21    provides contact information, including names, addresses,
22    and phone numbers for the next closest contracted provider
23    or facility;
24        (2) if patterns of care in the service area do not
25    support the need for the requested number of provider or
26    facility type and the insurer provides data on local

 

 

HB2472- 13 -LRB103 28761 BMS 55144 b

1    patterns of care, such as claims data, referral patterns,
2    or local provider interviews, indicating where the
3    beneficiaries currently seek this type of care or where
4    the physicians currently refer beneficiaries, or both; or
5        (3) other circumstances deemed appropriate by the
6    Department consistent with the requirements of this Act.
7    (h) Insurers are required to report to the Director any
8material change to an approved network plan within 15 days
9after the change occurs and any change that would result in
10failure to meet the requirements of this Act. Upon notice from
11the insurer, the Director shall reevaluate the network plan's
12compliance with the network adequacy and transparency
13standards of this Act.
14(Source: P.A. 102-144, eff. 1-1-22; 102-901, eff. 7-1-22;
15102-1117, eff. 1-13-23.)
 
16    Section 15. The Managed Care Reform and Patient Rights Act
17is amended by changing Sections 10, 45, 70, and 85 as follows:
 
18    (215 ILCS 134/10)
19    Sec. 10. Definitions.
20    "Adverse determination" means, for a determination by a
21health care plan under Section 45 or for by a utilization
22review program under Section 85, an adverse determination as
23defined in Section 10 of the Health Carrier External Review
24Act that a health care service is not medically necessary.

 

 

HB2472- 14 -LRB103 28761 BMS 55144 b

1    "Clinical peer" means a health care professional who is in
2the same profession and the same or similar specialty as the
3health care provider who typically manages the medical
4condition, procedures, or treatment under review.
5    "Department" means the Department of Insurance.
6    "Emergency medical condition" means a medical condition
7manifesting itself by acute symptoms of sufficient severity,
8regardless of the final diagnosis given, such that a prudent
9layperson, who possesses an average knowledge of health and
10medicine, could reasonably expect the absence of immediate
11medical attention to result in:
12        (1) placing the health of the individual (or, with
13    respect to a pregnant woman, the health of the woman or her
14    unborn child) in serious jeopardy;
15        (2) serious impairment to bodily functions;
16        (3) serious dysfunction of any bodily organ or part;
17        (4) inadequately controlled pain; or
18        (5) with respect to a pregnant woman who is having
19    contractions:
20            (A) inadequate time to complete a safe transfer to
21        another hospital before delivery; or
22            (B) a transfer to another hospital may pose a
23        threat to the health or safety of the woman or unborn
24        child.
25    "Emergency medical screening examination" means a medical
26screening examination and evaluation by a physician licensed

 

 

HB2472- 15 -LRB103 28761 BMS 55144 b

1to practice medicine in all its branches, or to the extent
2permitted by applicable laws, by other appropriately licensed
3personnel under the supervision of or in collaboration with a
4physician licensed to practice medicine in all its branches to
5determine whether the need for emergency services exists.
6    "Emergency services" means, with respect to an enrollee of
7a health care plan, transportation services, including but not
8limited to ambulance services, and covered inpatient and
9outpatient hospital services furnished by a provider qualified
10to furnish those services that are needed to evaluate or
11stabilize an emergency medical condition. "Emergency services"
12does not refer to post-stabilization medical services.
13    "Enrollee" means any person and his or her dependents
14enrolled in or covered by a health care plan.
15    "Health care plan" means a plan, including, but not
16limited to, a health maintenance organization, a managed care
17community network as defined in the Illinois Public Aid Code,
18or an accountable care entity as defined in the Illinois
19Public Aid Code that receives capitated payments to cover
20medical services from the Department of Healthcare and Family
21Services, that establishes, operates, or maintains a network
22of health care providers that has entered into an agreement
23with the plan to provide health care services to enrollees to
24whom the plan has the ultimate obligation to arrange for the
25provision of or payment for services through organizational
26arrangements for ongoing quality assurance, utilization review

 

 

HB2472- 16 -LRB103 28761 BMS 55144 b

1programs, or dispute resolution. Nothing in this definition
2shall be construed to mean that an independent practice
3association or a physician hospital organization that
4subcontracts with a health care plan is, for purposes of that
5subcontract, a health care plan.
6    For purposes of this definition, "health care plan" shall
7not include the following:
8        (1) indemnity health insurance policies including
9    those using a contracted provider network;
10        (2) health care plans that offer only dental or only
11    vision coverage;
12        (3) preferred provider administrators, as defined in
13    Section 370g(g) of the Illinois Insurance Code;
14        (4) employee or employer self-insured health benefit
15    plans under the federal Employee Retirement Income
16    Security Act of 1974;
17        (5) health care provided pursuant to the Workers'
18    Compensation Act or the Workers' Occupational Diseases
19    Act; and
20        (6) not-for-profit voluntary health services plans
21    with health maintenance organization authority in
22    existence as of January 1, 1999 that are affiliated with a
23    union and that only extend coverage to union members and
24    their dependents.
25    "Health care professional" means a physician, a registered
26professional nurse, or other individual appropriately licensed

 

 

HB2472- 17 -LRB103 28761 BMS 55144 b

1or registered to provide health care services.
2    "Health care provider" means any physician, hospital
3facility, facility licensed under the Nursing Home Care Act,
4long-term care facility as defined in Section 1-113 of the
5Nursing Home Care Act, or other person that is licensed or
6otherwise authorized to deliver health care services. Nothing
7in this Act shall be construed to define Independent Practice
8Associations or Physician-Hospital Organizations as health
9care providers.
10    "Health care services" means any services included in the
11furnishing to any individual of medical care, or the
12hospitalization incident to the furnishing of such care, as
13well as the furnishing to any person of any and all other
14services for the purpose of preventing, alleviating, curing,
15or healing human illness or injury including behavioral
16health, mental health, home health, and pharmaceutical
17services and products.
18    "Medical director" means a physician licensed in any state
19to practice medicine in all its branches appointed by a health
20care plan.
21    "Person" means a corporation, association, partnership,
22limited liability company, sole proprietorship, or any other
23legal entity.
24    "Physician" means a person licensed under the Medical
25Practice Act of 1987.
26    "Post-stabilization medical services" means health care

 

 

HB2472- 18 -LRB103 28761 BMS 55144 b

1services provided to an enrollee that are furnished in a
2licensed hospital by a provider that is qualified to furnish
3such services, and determined to be medically necessary and
4directly related to the emergency medical condition following
5stabilization.
6    "Stabilization" means, with respect to an emergency
7medical condition, to provide such medical treatment of the
8condition as may be necessary to assure, within reasonable
9medical probability, that no material deterioration of the
10condition is likely to result.
11    "Utilization review" means the evaluation of the medical
12necessity, appropriateness, and efficiency of the use of
13health care services, procedures, and facilities, including
14any process implemented by human or automated means to decide
15whether to render an adverse determination.
16    "Utilization review program" means a program established
17by a person to perform utilization review.
18(Source: P.A. 101-452, eff. 1-1-20; 102-409, eff. 1-1-22.)
 
19    (215 ILCS 134/45)
20    Sec. 45. Health care services appeals, complaints, and
21external independent reviews.
22    (a) A health care plan shall establish and maintain an
23appeals procedure as outlined in this Act. Compliance with
24this Act's appeals procedures shall satisfy a health care
25plan's obligation to provide appeal procedures under any other

 

 

HB2472- 19 -LRB103 28761 BMS 55144 b

1State law or rules. All appeals of a health care plan's
2administrative determinations and complaints regarding its
3administrative decisions shall be handled as required under
4Section 50.
5    (b) When an appeal concerns a decision or action by a
6health care plan, its employees, or its subcontractors that
7relates to (i) health care services, including, but not
8limited to, procedures or treatments, for an enrollee with an
9ongoing course of treatment ordered by a health care provider,
10the denial of which could significantly increase the risk to
11an enrollee's health, or (ii) a treatment referral, service,
12procedure, or other health care service, the denial of which
13could significantly increase the risk to an enrollee's health,
14the health care plan must allow for the filing of an appeal
15either orally or in writing. Upon submission of the appeal, a
16health care plan must notify the party filing the appeal, as
17soon as possible, but in no event more than 24 hours after the
18submission of the appeal, of all information that the plan
19requires to evaluate the appeal. The health care plan shall
20render a decision on the appeal within 24 hours after receipt
21of the required information. The health care plan shall notify
22the party filing the appeal and the enrollee, enrollee's
23primary care physician, and any health care provider who
24recommended the health care service involved in the appeal of
25its decision orally followed-up by a written notice of the
26determination.

 

 

HB2472- 20 -LRB103 28761 BMS 55144 b

1    (c) For all appeals related to health care services
2including, but not limited to, procedures or treatments for an
3enrollee and not covered by subsection (b) above, the health
4care plan shall establish a procedure for the filing of such
5appeals. Upon submission of an appeal under this subsection, a
6health care plan must notify the party filing an appeal,
7within 3 business days, of all information that the plan
8requires to evaluate the appeal. The health care plan shall
9render a decision on the appeal within 15 business days after
10receipt of the required information. The health care plan
11shall notify the party filing the appeal, the enrollee, the
12enrollee's primary care physician, and any health care
13provider who recommended the health care service involved in
14the appeal orally of its decision followed-up by a written
15notice of the determination.
16    (d) An appeal under subsection (b) or (c) may be filed by
17the enrollee, the enrollee's designee or guardian, the
18enrollee's primary care physician, or the enrollee's health
19care provider. A health care plan shall designate a clinical
20peer to review appeals, because these appeals pertain to
21medical or clinical matters and such an appeal must be
22reviewed by an appropriate health care professional. No one
23reviewing an appeal may have had any involvement in the
24initial determination that is the subject of the appeal. The
25written notice of determination required under subsections (b)
26and (c) shall include (i) clear and detailed reasons for the

 

 

HB2472- 21 -LRB103 28761 BMS 55144 b

1determination, (ii) the medical or clinical criteria for the
2determination, which shall be based upon sound clinical
3evidence and reviewed on a periodic basis, and (iii) in the
4case of an adverse determination, the procedures for
5requesting an external independent review as provided by the
6Illinois Health Carrier External Review Act.
7    (e) If an appeal filed under subsection (b) or (c) is
8denied for a reason including, but not limited to, the
9service, procedure, or treatment is not viewed as medically
10necessary, denial of specific tests or procedures, denial of
11referral to specialist physicians or denial of hospitalization
12requests or length of stay requests, any involved party may
13request an external independent review as provided by the
14Illinois Health Carrier External Review Act.
15    (f) Until July 1, 2013, if an external independent review
16decision made pursuant to the Illinois Health Carrier External
17Review Act upholds a determination adverse to the covered
18person, the covered person has the right to appeal the final
19decision to the Department; if the external review decision is
20found by the Director to have been arbitrary and capricious,
21then the Director, with consultation from a licensed medical
22professional, may overturn the external review decision and
23require the health carrier to pay for the health care service
24or treatment; such decision, if any, shall be made solely on
25the legal or medical merits of the claim. If an external review
26decision is overturned by the Director pursuant to this

 

 

HB2472- 22 -LRB103 28761 BMS 55144 b

1Section and the health carrier so requests, then the Director
2shall assign a new independent review organization to
3reconsider the overturned decision. The new independent review
4organization shall follow subsection (d) of Section 40 of the
5Health Carrier External Review Act in rendering a decision.
6    (g) Future contractual or employment action by the health
7care plan regarding the patient's physician or other health
8care provider shall not be based solely on the physician's or
9other health care provider's participation in health care
10services appeals, complaints, or external independent reviews
11under the Illinois Health Carrier External Review Act.
12    (h) Nothing in this Section shall be construed to require
13a health care plan to pay for a health care service not covered
14under the enrollee's certificate of coverage or policy.
15    (i) If a health care plan uses an automated process to make
16an initial adverse determination or relies on a utilization
17review organization's automated process for an initial adverse
18determination, the health care plan shall ensure that any
19appeal is processed as required by this Section, including the
20restriction that only a clinical peer may review an appeal. A
21health care plan using an automated process to make an initial
22adverse determination shall have the accreditation, the
23policies, and the procedures required by subsection (b-10) of
24Section 85.
25(Source: P.A. 96-857, eff. 7-1-10.)
 

 

 

HB2472- 23 -LRB103 28761 BMS 55144 b

1    (215 ILCS 134/70)
2    Sec. 70. Post-stabilization medical services.
3    (a) If prior authorization for covered post-stabilization
4services is required by the health care plan, the plan shall
5provide access 24 hours a day, 7 days a week to persons
6designated by the plan to make such determinations, provided
7that any determination made under this Section must be made by
8a health care professional. The review shall be resolved in
9accordance with the provisions of Section 85 and the time
10requirements of this Section.
11    (a-5) Prior authorization or approval by the plan shall
12not be required for post-stabilization services that
13constitute emergency services under Section 356z.3a of the
14Illinois Insurance Code.
15    (b) The treating physician licensed to practice medicine
16in all its branches or health care provider shall contact the
17health care plan or delegated health care provider as
18designated on the enrollee's health insurance card to obtain
19authorization, denial, or arrangements for an alternate plan
20of treatment or transfer of the enrollee.
21    (c) The treating physician licensed to practice medicine
22in all its branches or health care provider shall document in
23the enrollee's medical record the enrollee's presenting
24symptoms; emergency medical condition; and time, phone number
25dialed, and result of the communication for request for
26authorization of post-stabilization medical services. The

 

 

HB2472- 24 -LRB103 28761 BMS 55144 b

1health care plan shall provide reimbursement for covered
2post-stabilization medical services if:
3        (1) authorization to render them is received from the
4    health care plan or its delegated health care provider, or
5        (2) after 2 documented good faith efforts, the
6    treating health care provider has attempted to contact the
7    enrollee's health care plan or its delegated health care
8    provider, as designated on the enrollee's health insurance
9    card, for prior authorization of post-stabilization
10    medical services and neither the plan nor designated
11    persons were accessible or the authorization was not
12    denied within 60 minutes of the request. "Two documented
13    good faith efforts" means the health care provider has
14    called the telephone number on the enrollee's health
15    insurance card or other available number either 2 times or
16    one time and an additional call to any referral number
17    provided. "Good faith" means honesty of purpose, freedom
18    from intention to defraud, and being faithful to one's
19    duty or obligation. For the purpose of this Act, good
20    faith shall be presumed.
21    (d) After rendering any post-stabilization medical
22services, the treating physician licensed to practice medicine
23in all its branches or health care provider shall continue to
24make every reasonable effort to contact the health care plan
25or its delegated health care provider regarding authorization,
26denial, or arrangements for an alternate plan of treatment or

 

 

HB2472- 25 -LRB103 28761 BMS 55144 b

1transfer of the enrollee until the treating health care
2provider receives instructions from the health care plan or
3delegated health care provider for continued care or the care
4is transferred to another health care provider or the patient
5is discharged.
6    (e) Payment for covered post-stabilization services may be
7denied:
8        (1) if the treating health care provider does not meet
9    the conditions outlined in subsection (c);
10        (2) upon determination that the post-stabilization
11    services claimed were not performed;
12        (3) upon timely determination that the
13    post-stabilization services rendered were contrary to the
14    instructions of the health care plan or its delegated
15    health care provider if contact was made between those
16    parties prior to the service being rendered;
17        (4) upon determination that the patient receiving such
18    services was not an enrollee of the health care plan; or
19        (5) upon material misrepresentation by the enrollee or
20    health care provider; "material" means a fact or situation
21    that is not merely technical in nature and results or
22    could result in a substantial change in the situation.
23    (f) Nothing in this Section prohibits a health care plan
24from delegating tasks associated with the responsibilities
25enumerated in this Section to the health care plan's
26contracted health care providers or another entity. Only a

 

 

HB2472- 26 -LRB103 28761 BMS 55144 b

1clinical peer may make an adverse determination, except that
2an automated process of a health care plan or registered
3utilization review program may make an initial adverse
4determination for services not included under subsection
5(a-5). However, the ultimate responsibility for coverage and
6payment decisions may not be delegated.
7    (g) Coverage and payment for post-stabilization medical
8services for which prior authorization or deemed approval is
9received shall not be retrospectively denied, including a
10retrospective denial through an adverse determination made by
11any human or automated process.
12    (h) Nothing in this Section shall prohibit the imposition
13of deductibles, copayments, and co-insurance. Nothing in this
14Section alters the prohibition on billing enrollees contained
15in the Health Maintenance Organization Act.
16(Source: P.A. 102-901, eff. 7-1-22.)
 
17    (215 ILCS 134/85)
18    Sec. 85. Utilization review program registration.
19    (a) No person may conduct a utilization review program in
20this State unless once every 2 years the person registers the
21utilization review program with the Department and provides
22proof of current accreditation for itself and its
23subcontractors certifies compliance with the Health
24Utilization Management Standards of the American Accreditation
25Healthcare Commission (URAC) or another accreditation entity

 

 

HB2472- 27 -LRB103 28761 BMS 55144 b

1authorized under this Section sufficient to achieve American
2Accreditation Healthcare Commission (URAC) accreditation or
3submits evidence of accreditation by the American
4Accreditation Healthcare Commission (URAC) for its Health
5Utilization Management Standards. Nothing in this Act shall be
6construed to require a health care plan or its subcontractors
7to become American Accreditation Healthcare Commission (URAC)
8accredited.
9    (b) In addition, the Director of the Department, in
10consultation with the Director of the Department of Public
11Health, may certify alternative utilization review standards
12of national accreditation organizations or entities in order
13for plans to comply with this Section. Any alternative
14utilization review standards shall meet or exceed those
15standards required under subsection (a).
16    (b-5) The Department shall recognize the Accreditation
17Association for Ambulatory Health Care among the list of
18accreditors from which utilization organizations may receive
19accreditation and qualify for reduced registration and renewal
20fees.
21    (b-10) Utilization review programs that use automated
22processes to render an adverse determination shall base all
23adverse determinations on objective, evidence-based criteria
24that have been accredited by the American Accreditation
25Healthcare Commission (URAC) or by the National Committee for
26Quality Assurance (NCQA) and shall provide proof of such

 

 

HB2472- 28 -LRB103 28761 BMS 55144 b

1accreditation to the Department with the registration required
2under subsection (a), including any renewal registrations. The
3utilization review program shall include with its registration
4materials attachments that contain policies and procedures:
5        (1) to ensure that licensed physicians with relevant
6    board certifications establish all criteria used for
7    adverse determinations; and
8        (2) for a program integrity system that, both before
9    new or revised criteria are used for adverse
10    determinations and when implementation errors in the
11    automated process are identified after new or revised
12    criteria go into effect, requires licensed physicians with
13    relevant board certifications to verify that the automated
14    process and corrections to it yield adverse determinations
15    consistent with the criteria for their certified field.
16    (c) The provisions of this Section do not apply to:
17        (1) persons providing utilization review program
18    services only to the federal government;
19        (2) self-insured health plans under the federal
20    Employee Retirement Income Security Act of 1974, however,
21    this Section does apply to persons conducting a
22    utilization review program on behalf of these health
23    plans;
24        (3) hospitals and medical groups performing
25    utilization review activities for internal purposes unless
26    the utilization review program is conducted for another

 

 

HB2472- 29 -LRB103 28761 BMS 55144 b

1    person.
2    Nothing in this Act prohibits a health care plan or other
3entity from contractually requiring an entity designated in
4item (3) of this subsection to adhere to the utilization
5review program requirements of this Act.
6    (d) This registration shall include submission of all of
7the following information regarding utilization review program
8activities:
9        (1) The name, address, and telephone number of the
10    utilization review programs.
11        (2) The organization and governing structure of the
12    utilization review programs.
13        (3) The number of lives for which utilization review
14    is conducted by each utilization review program.
15        (4) Hours of operation of each utilization review
16    program.
17        (5) Description of the grievance process for each
18    utilization review program.
19        (6) Number of covered lives for which utilization
20    review was conducted for the previous calendar year for
21    each utilization review program.
22        (7) Written policies and procedures for protecting
23    confidential information according to applicable State and
24    federal laws for each utilization review program.
25    (e) (1) A utilization review program shall have written
26procedures for assuring that patient-specific information

 

 

HB2472- 30 -LRB103 28761 BMS 55144 b

1obtained during the process of utilization review will be:
2        (A) kept confidential in accordance with applicable
3    State and federal laws; and
4        (B) shared only with the enrollee, the enrollee's
5    designee, the enrollee's health care provider, and those
6    who are authorized by law to receive the information.
7    Summary data shall not be considered confidential if it
8does not provide information to allow identification of
9individual patients or health care providers.
10        (2) Except as otherwise permitted by this Section for
11    an accredited automated process, only Only a health care
12    professional may make adverse determinations regarding the
13    medical necessity of health care services during the
14    course of utilization review.
15        (3) When making retrospective reviews, utilization
16    review programs shall base reviews solely on the medical
17    information available to the attending physician or
18    ordering provider at the time the health care services
19    were provided. This paragraph includes billing records and
20    diagnosis or procedure codes that substantively contain
21    the same medical information to an equal or lesser degree
22    of specificity as the records that the attending physician
23    or ordering provider directly consulted at the time that
24    health care services were provided.
25        (4) When making prospective, concurrent, and
26    retrospective determinations, utilization review programs

 

 

HB2472- 31 -LRB103 28761 BMS 55144 b

1    shall collect only information that is necessary to make
2    the determination and shall not routinely require health
3    care providers to numerically code diagnoses or procedures
4    to be considered for certification, unless required under
5    State or federal Medicare or Medicaid rules or
6    regulations, but may request such code if available, or
7    routinely request copies of medical records of all
8    enrollees reviewed. During prospective or concurrent
9    review, copies of medical records shall only be required
10    when necessary to verify that the health care services
11    subject to review are medically necessary. In these cases,
12    only the necessary or relevant sections of the medical
13    record shall be required.
14    (f) If the Department finds that a utilization review
15program is not in compliance with this Section, the Department
16shall issue a corrective action plan and allow a reasonable
17amount of time for compliance with the plan. If the
18utilization review program does not come into compliance, the
19Department may issue a cease and desist order. Before issuing
20a cease and desist order under this Section, the Department
21shall provide the utilization review program with a written
22notice of the reasons for the order and allow a reasonable
23amount of time to supply additional information demonstrating
24compliance with requirements of this Section and to request a
25hearing. The hearing notice shall be sent by certified mail,
26return receipt requested, and the hearing shall be conducted

 

 

HB2472- 32 -LRB103 28761 BMS 55144 b

1in accordance with the Illinois Administrative Procedure Act.
2    (g) A utilization review program subject to a corrective
3action may continue to conduct business until a final decision
4has been issued by the Department.
5    (h) Any adverse determination made by a health care plan
6or its subcontractors may be appealed in accordance with
7subsection (f) of Section 45.
8    (i) The Director may by rule establish a registration fee
9for each person conducting a utilization review program. All
10fees paid to and collected by the Director under this Section
11shall be deposited into the Insurance Producer Administration
12Fund.
13    (j) If a utilization review program uses an automated
14process to make an initial adverse determination, nothing in
15this Section shall allow any appeal to be processed contrary
16to the requirements of this Act, including the requirement for
17a clinical peer to review the appeal. Nothing in this Section
18requires a utilization review program that renders an initial
19adverse determination to review the clinical appeal of its
20determination if the plan or coverage ensures that either the
21plan or an accredited utilization review program reviews the
22appeal in compliance with this Act.
23(Source: P.A. 99-111, eff. 1-1-16.)
 
24    Section 20. The Health Carrier External Review Act is
25amended by changing Section 10 as follows:
 

 

 

HB2472- 33 -LRB103 28761 BMS 55144 b

1    (215 ILCS 180/10)
2    Sec. 10. Definitions. For the purposes of this Act:
3    "Adverse determination" means:
4        (1) a determination by a health carrier or its
5    designee utilization review organization that, based upon
6    the health information provided, a request for a benefit,
7    including any quantity, frequency, duration, or other
8    measurement of a benefit, under the health carrier's
9    health benefit plan upon application of any utilization
10    review technique does not meet the health carrier's
11    requirements for medical necessity, appropriateness,
12    health care setting, level of care, or effectiveness or is
13    determined to be experimental or investigational and the
14    requested benefit is therefore denied, reduced, or
15    terminated or payment is not provided or made, in whole or
16    in part, for the benefit;
17        (2) the denial, reduction, or termination of or
18    failure to provide or make payment, in whole or in part,
19    for a benefit based on a determination by a health carrier
20    or its designee utilization review organization that a
21    preexisting condition was present before the effective
22    date of coverage; or
23        (3) a rescission of coverage determination, which does
24    not include a cancellation or discontinuance of coverage
25    that is attributable to a failure to timely pay required

 

 

HB2472- 34 -LRB103 28761 BMS 55144 b

1    premiums or contributions towards the cost of coverage.
2    "Adverse determination" includes determinations that
3replace the requested health care service with an approval of
4an alternative health care service, or that condition approval
5of the requested service on first trying an alternative health
6care service, if the requested service was not generally
7excluded under the plan or if the request was made under a
8medical exceptions procedure. "Adverse determination" includes
9determinations made based on any source of health information
10pertaining to the covered person that is used to deny, reduce,
11replace, condition, or terminate the benefit or payment.
12    "Authorized representative" means:
13        (1) a person to whom a covered person has given
14    express written consent to represent the covered person
15    for purposes of this Law;
16        (2) a person authorized by law to provide substituted
17    consent for a covered person;
18        (3) a family member of the covered person or the
19    covered person's treating health care professional when
20    the covered person is unable to provide consent;
21        (4) a health care provider when the covered person's
22    health benefit plan requires that a request for a benefit
23    under the plan be initiated by the health care provider;
24    or
25        (5) in the case of an urgent care request, a health
26    care provider with knowledge of the covered person's

 

 

HB2472- 35 -LRB103 28761 BMS 55144 b

1    medical condition.
2    "Best evidence" means evidence based on:
3        (1) randomized clinical trials;
4        (2) if randomized clinical trials are not available,
5    then cohort studies or case-control studies;
6        (3) if items (1) and (2) are not available, then
7    case-series; or
8        (4) if items (1), (2), and (3) are not available, then
9    expert opinion.
10    "Case-series" means an evaluation of a series of patients
11with a particular outcome, without the use of a control group.
12    "Clinical review criteria" means the written screening
13procedures, decision abstracts, clinical protocols, and
14practice guidelines used by a health carrier to determine the
15necessity and appropriateness of health care services.
16    "Cohort study" means a prospective evaluation of 2 groups
17of patients with only one group of patients receiving specific
18intervention.
19    "Concurrent review" means a review conducted during a
20patient's stay or course of treatment in a facility, the
21office of a health care professional, or other inpatient or
22outpatient health care setting.
23    "Covered benefits" or "benefits" means those health care
24services to which a covered person is entitled under the terms
25of a health benefit plan.
26    "Covered person" means a policyholder, subscriber,

 

 

HB2472- 36 -LRB103 28761 BMS 55144 b

1enrollee, or other individual participating in a health
2benefit plan.
3    "Director" means the Director of the Department of
4Insurance.
5    "Emergency medical condition" means a medical condition
6manifesting itself by acute symptoms of sufficient severity,
7including, but not limited to, severe pain, such that a
8prudent layperson who possesses an average knowledge of health
9and medicine could reasonably expect the absence of immediate
10medical attention to result in:
11        (1) placing the health of the individual or, with
12    respect to a pregnant woman, the health of the woman or her
13    unborn child, in serious jeopardy;
14        (2) serious impairment to bodily functions; or
15        (3) serious dysfunction of any bodily organ or part.
16    "Emergency services" means health care items and services
17furnished or required to evaluate and treat an emergency
18medical condition.
19    "Evidence-based standard" means the conscientious,
20explicit, and judicious use of the current best evidence based
21on an overall systematic review of the research in making
22decisions about the care of individual patients.
23    "Expert opinion" means a belief or an interpretation by
24specialists with experience in a specific area about the
25scientific evidence pertaining to a particular service,
26intervention, or therapy.

 

 

HB2472- 37 -LRB103 28761 BMS 55144 b

1    "Facility" means an institution providing health care
2services or a health care setting.
3    "Final adverse determination" means an adverse
4determination involving a covered benefit that has been upheld
5by a health carrier, or its designee utilization review
6organization, at the completion of the health carrier's
7internal grievance process procedures as set forth by the
8Managed Care Reform and Patient Rights Act.
9    "Health benefit plan" means a policy, contract,
10certificate, plan, or agreement offered or issued by a health
11carrier to provide, deliver, arrange for, pay for, or
12reimburse any of the costs of health care services.
13    "Health care provider" or "provider" means a physician,
14hospital facility, or other health care practitioner licensed,
15accredited, or certified to perform specified health care
16services consistent with State law, responsible for
17recommending health care services on behalf of a covered
18person.
19    "Health care services" means services for the diagnosis,
20prevention, treatment, cure, or relief of a health condition,
21illness, injury, or disease.
22    "Health carrier" means an entity subject to the insurance
23laws and regulations of this State, or subject to the
24jurisdiction of the Director, that contracts or offers to
25contract to provide, deliver, arrange for, pay for, or
26reimburse any of the costs of health care services, including

 

 

HB2472- 38 -LRB103 28761 BMS 55144 b

1a sickness and accident insurance company, a health
2maintenance organization, or any other entity providing a plan
3of health insurance, health benefits, or health care services.
4"Health carrier" also means Limited Health Service
5Organizations (LHSO) and Voluntary Health Service Plans.
6    "Health information" means information or data, whether
7oral or recorded in any form or medium, and personal facts or
8information about events or relationships that relate to:
9        (1) the past, present, or future physical, mental, or
10    behavioral health or condition of an individual or a
11    member of the individual's family;
12        (2) the provision of health care services to an
13    individual; or
14        (3) payment for the provision of health care services
15    to an individual.
16    "Independent review organization" means an entity that
17conducts independent external reviews of adverse
18determinations and final adverse determinations.
19    "Medical or scientific evidence" means evidence found in
20the following sources:
21        (1) peer-reviewed scientific studies published in or
22    accepted for publication by medical journals that meet
23    nationally recognized requirements for scientific
24    manuscripts and that submit most of their published
25    articles for review by experts who are not part of the
26    editorial staff;

 

 

HB2472- 39 -LRB103 28761 BMS 55144 b

1        (2) peer-reviewed medical literature, including
2    literature relating to therapies reviewed and approved by
3    a qualified institutional review board, biomedical
4    compendia, and other medical literature that meet the
5    criteria of the National Institutes of Health's Library of
6    Medicine for indexing in Index Medicus (Medline) and
7    Elsevier Science Ltd. for indexing in Excerpta Medicus
8    (EMBASE);
9        (3) medical journals recognized by the Secretary of
10    Health and Human Services under Section 1861(t)(2) of the
11    federal Social Security Act;
12        (4) the following standard reference compendia:
13            (a) The American Hospital Formulary Service-Drug
14        Information;
15            (b) Drug Facts and Comparisons;
16            (c) The American Dental Association Accepted
17        Dental Therapeutics; and
18            (d) The United States Pharmacopoeia-Drug
19        Information;
20        (5) findings, studies, or research conducted by or
21    under the auspices of federal government agencies and
22    nationally recognized federal research institutes,
23    including:
24            (a) the federal Agency for Healthcare Research and
25        Quality;
26            (b) the National Institutes of Health;

 

 

HB2472- 40 -LRB103 28761 BMS 55144 b

1            (c) the National Cancer Institute;
2            (d) the National Academy of Sciences;
3            (e) the Centers for Medicare & Medicaid Services;
4            (f) the federal Food and Drug Administration; and
5            (g) any national board recognized by the National
6        Institutes of Health for the purpose of evaluating the
7        medical value of health care services; or
8        (6) any other medical or scientific evidence that is
9    comparable to the sources listed in items (1) through (5).
10    "Person" means an individual, a corporation, a
11partnership, an association, a joint venture, a joint stock
12company, a trust, an unincorporated organization, any similar
13entity, or any combination of the foregoing.
14    "Prospective review" means a review conducted prior to an
15admission or the provision of a health care service or a course
16of treatment in accordance with a health carrier's requirement
17that the health care service or course of treatment, in whole
18or in part, be approved prior to its provision.
19    "Protected health information" means health information
20(i) that identifies an individual who is the subject of the
21information; or (ii) with respect to which there is a
22reasonable basis to believe that the information could be used
23to identify an individual.
24    "Randomized clinical trial" means a controlled prospective
25study of patients that have been randomized into an
26experimental group and a control group at the beginning of the

 

 

HB2472- 41 -LRB103 28761 BMS 55144 b

1study with only the experimental group of patients receiving a
2specific intervention, which includes study of the groups for
3variables and anticipated outcomes over time.
4    "Retrospective review" means any review of a request for a
5benefit that is not a concurrent or prospective review
6request. "Retrospective review" does not include the review of
7a claim that is limited to veracity of documentation or
8accuracy of coding.
9    "Utilization review" has the meaning provided by the
10Managed Care Reform and Patient Rights Act.
11    "Utilization review organization" means a utilization
12review program as defined in the Managed Care Reform and
13Patient Rights Act.
14(Source: P.A. 97-574, eff. 8-26-11; 97-813, eff. 7-13-12;
1598-756, eff. 7-16-14.)
 
16    Section 25. The Prior Authorization Reform Act is amended
17by changing Section 55 as follows:
 
18    (215 ILCS 200/55)
19    Sec. 55. Denial.
20    (a) The health insurance issuer or its contracted
21utilization review organization may not revoke or further
22limit, condition, or restrict a previously issued prior
23authorization approval while it remains valid under this Act.
24    (b) Notwithstanding any other provision of law, if a claim

 

 

HB2472- 42 -LRB103 28761 BMS 55144 b

1is properly coded and submitted timely to a health insurance
2issuer, the health insurance issuer shall make payment
3according to the terms of coverage on claims for health care
4services for which prior authorization was required and
5approval received before the rendering of health care
6services, unless one of the following occurs:
7        (1) it is timely determined that the enrollee's health
8    care professional or health care provider knowingly
9    provided health care services that required prior
10    authorization from the health insurance issuer or its
11    contracted utilization review organization without first
12    obtaining prior authorization for those health care
13    services;
14        (2) it is timely determined that the health care
15    services claimed were not performed;
16        (3) it is timely determined that the health care
17    services rendered were contrary to the instructions of the
18    health insurance issuer or its contracted utilization
19    review organization or delegated reviewer if contact was
20    made between those parties before the service being
21    rendered;
22        (4) it is timely determined that the enrollee
23    receiving such health care services was not an enrollee of
24    the health care plan; or
25        (5) the approval was based upon a material
26    misrepresentation by the enrollee, health care

 

 

HB2472- 43 -LRB103 28761 BMS 55144 b

1    professional, or health care provider; as used in this
2    paragraph (5), "material" means a fact or situation that
3    is not merely technical in nature and results or could
4    result in a substantial change in the situation.
5    (c) Nothing in this Section shall preclude a utilization
6review organization or a health insurance issuer from
7performing post-service reviews of health care claims for
8purposes of payment integrity or for the prevention of fraud,
9waste, or abuse.
10    (d) If a health insurance issuer imposes a penalty for the
11failure to obtain any form of prior authorization for any
12health care service, the penalty may not exceed the lesser of:
13        (1) the actual cost of the health care service; or
14        (2) $1,000 per occurrence in addition to the plan
15    cost-sharing provisions.
16    (e) A health insurance issuer may not require both the
17enrollee and the health care professional or health care
18provider to obtain any form of prior authorization for the
19same instance of a health care service, nor otherwise require
20more than one prior authorization for the same instance of a
21health care service.
22(Source: P.A. 102-409, eff. 1-1-22.)
 
23    Section 99. Effective date. This Act takes effect January
241, 2024.

 

 

HB2472- 44 -LRB103 28761 BMS 55144 b

1 INDEX
2 Statutes amended in order of appearance
3    215 ILCS 5/155.36
4    215 ILCS 5/370s
5    215 ILCS 124/10
6    215 ILCS 134/10
7    215 ILCS 134/45
8    215 ILCS 134/70
9    215 ILCS 134/85
10    215 ILCS 180/10
11    215 ILCS 200/55